Divis Labs net profit up 13 percent at Rs 557 crore in Q1
Advertisement
New Delhi: Drug maker Divi's Laboratories on Saturday posted a 13 percent increase in its consolidated net profit at Rs 557 crore for the first quarter ended June 30, 2021.
The company had reported a net profit of Rs 492 crore in the April-June quarter of the previous fiscal.
Total income rose to Rs 1,997 crore in the first quarter as compared with Rs 1,748 crore in the June quarter of 2020-21 fiscal, Divi's Laboratories said in a regulatory filing.
Read also: Sun Pharma reports consolidated net profit of Rs 1,444 crore in Q1
Forex gain for the current quarter stood at Rs 20 crore as against a gain of Rs 5 crore during the corresponding quarter of the last year, it added.
Read also: Piramal net profit up 8 percent to Rs 534 crore in Q1
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.